Comvita Limited

Comvita Limited

CVNZF
Comvita LimitedUS flagOther OTC
0.42
USD
- -
- -
30.05MMarket Cap
2012 Y
2013 Y
2014 Y
2015 Y
2017 Y
2018 Y
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
Revenue per Share
3.06
3.25
3.4
4.01
3.36
3.77
3.33
3.76
2.69
2.91
3.28
2.85
- -
Basic EPS, GAAP
0.27
0.23
0.23
0.28
0.22
0.17
-0.55
-0.19
0.13
0.18
0.15
-1.08
- -
Free Cash Flow per Basic Share
-0.18
-0.36
-0.49
-0.37
-0.09
-0.11
-0.33
-0.11
-0.15
-0.13
-0.29
-0.14
- -
Dividend per Share
0.07
0.13
0.12
0.11
0.04
0.04
0.02
- -
- -
0.07
0.06
0.04
- -
Book Value per Share
2.28
2.4
2.66
3.24
3.72
3.93
3.54
4.21
3.2
3.27
3.39
2.27
- -
Tangible Book Value per Share
1.1
1.28
1.39
2.01
2.86
3.17
2.65
3.31
2.58
2.62
2.76
2.14
- -
Basic Weighted Avg Shares
31
31
33
38
45
49
51
52
71
72
71
72
70
Sales/Revenue/Turnover
95
102
114
151
153
186
169
195
192
209
234
204
- -
Operating Margin (%)
11.17
8.88
6.34
6.5
-4.26
8.49
-6.76
-3.66
-0.44
3.56
-0.08
-12.6
- -
Depreciation Expense
2
2
4
6
7
2
2
11
11
11
12
13
- -
Net Income, GAAP
8
7
8
11
10
8
-28
-10
9
13
11
-77
- -
Effective Tax Rate (%)
28.86
29.44
28.21
29.3
- -
26.29
- -
- -
29.27
25.35
14.95
- -
- -
Profit Margin (%)
8.66
7.23
6.86
6.99
6.44
4.41
-16.37
-4.97
4.94
6.11
4.72
-37.86
- -
Working Capital
23
34
34
61
130
168
155
129
123
140
164
62
- -
LT Debt
14
29
29
43
66
97
99
40
31
53
77
16
- -
Total Equity
76
82
87
119
164
190
173
212
222
228
239
161
- -
Return on Invested Capital (%)
8.13
6.22
4.45
4.9
- -
4.49
- -
- -
-0.23
2.04
-0.05
- -
- -
Return on Capital (%)
10.96
8.62
8.26
9.57
- -
4.52
- -
- -
4.22
5.31
6.49
- -
- -
Return on Common Equity (%)
12.23
10.11
9.47
10
6.76
4.53
-14.85
-4.87
4.24
5.53
4.64
-38.14
- -

Capital Structure

FRC

in mil. unless spec.
No data availableFinancial data will appear here once available

Working Capital

FRC

in mil. unless spec.
No data availableFinancial data will appear here once available

Growth Rates

FRC

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
- -
- -
- -
Free Cash Flow
- -
- -
- -
Net Income, GAAP
- -
- -
- -
Sales/Revenue/Turnover
- -
- -
- -
Total Cash Common Dividend
- -
- -
- -

Quarterly Revenue

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2023
- -
- -
- -
- -
234
2024
- -
- -
- -
- -
204
2025
- -
- -
- -
- -
- -

Quarterly Earnings Per Share

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2023
- -
- -
- -
- -
0.15
2024
- -
- -
- -
- -
-1.08
2025
- -
- -
- -
- -
- -

Quarterly Dividends Per Share

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2023
- -
- -
- -
- -
0.06
2024
- -
- -
- -
- -
0.04
2025
- -
- -
- -
- -
- -

Company Description

APIChat
CEO
Karl Gradon
Full Time Employees
400
Sector
Consumer Defensive
Industry
Packaged Foods
Address
23 Wilson Road South Te Puke New Zealand 3153
IPO Date
Sep 23, 2009
Business
Comvita Limited Comvita Limited (NZX:CVT) manufactures and markets natural health products derived from bee products and other natural ingredients, with a focus on Mānuka honey as its core offering. The company provides a range of products including Mānuka honey in various grades such as UMF-certified variants, propolis, olive leaf extracts, Medihoney wound care solutions, elixirs, lozenges, oral care items, kids' health supplements, bee pollen, cider vinegar, skincare products, and bundles or bulk packs; it operates across categories of healthcare, personal care, wound care, and functional foods. Founded in 1974 and headquartered in Te Puke, Bay of Plenty, New Zealand, Comvita conducts global operations in over 18 countries including Australia, China, Hong Kong, Japan, South Korea, the United Kingdom, the United States, North America, Southeast Asia, and Europe, supported by more than 550 employees, its own accredited laboratory for quality testing, and sustainable practices like native tree planting and B Corp certification achieved in 2023. Recent developments include the acquisition of HoneyWorld Singapore in 2023 for NZ$10.4 million to strengthen its Asian market presence and achieve category leadership in Mānuka honey there; a failed takeover bid in November 2025 by Florenz, a subsidiary of Mark Stewart's Masthead Limited, valued at $56.4 million, prompting an ongoing recapitalisation process with banking partners; key leadership appointments in November 2025 such as permanent Chief Financial Officer Mandy Tomkins-Dancey, Chief Operating Officer Ben Duncan, and Chief People and Culture Officer Nikki Leske to support its financial reset; and new product launches in digestive health, eyecare, immunity, seasonal gifting, and higher UMF Mānuka honey ranges to diversify offerings amid inventory reduction to below $85 million and a projected return to profitability in FY26 with revenue of $212.6 million.

Company News

APIChat
  • Comvita Limited (CVNZF) Q2 2026 Earnings Call Transcript